# Rainer Fietkau

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rainer-fietkau-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,429 |
| Field | Lung Cancer Diagnosis and Treatment |
| h-index | 45 |
| i10-index | 109 |
| Last Known Institution | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| OpenAlex ID | https://openalex.org/A5111831753 |
| Works | 263 |

## Researcher papers

- [Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer](https://scholariq.org/papers/neoadjuvant-chemoradiation-therapy-with-gemcitabine-cisplatin-and-surgery-versus/)
- [Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study](https://scholariq.org/papers/treatment-characteristics-and-real-world-progression-free-survival-in-patients/)

## Researcher topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Friedrich-Alexander-Universität Erlangen-Nürnberg](https://scholariq.org/institutions/friedrich-alexander-universitat-erlangen-nurnberg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.